Efficacy of Albumin Therapy With Standard Medical Treatment (SMT) as Compared to Standard Medical Treatment (SMT) in Improving Patient Survival and Immune Modulation in Patients With Acute on Chronic Liver Failure (ASIA Trial).

Exclusion Criteria

• •1. Patients who have already received albumin in last 1 week
• •2. Patients who require albumin like PICD (Paracentesis-Induced Circulatory Dysfunction)
• •,SBP (Spontaneous bacterial peritonitis),LVP(large volume paracentesis),HRS(hepatorenal syndrome)
• •3. Not given consent
• •4. Significant cardiopulmonary or structural heart disease/ CKD(chronic kidney diseses) /volume overload /upper GI bleed.
• •5. Pregnant/ HIV / HCC \>2cm size
• •6. Alcoholic hepatitis eligible for steroids
• •7. Previous known allergic/adverse reaction to albumin
• •8. Any clinical condition which the investigator considers would make the patient unsuitable for the trial
• •9. Patients who will receive palliative treatment only during their hospital admission